The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (16 analysts) rates it buy, with a mean price target of $103.
Textron
TXT · a US exchange · USD · Market cap $13.7B · 34,000 employees
Textron Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 10:31 UTC · 13 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Textron holds its Markdown at $79.89. Consolidating, no directional conviction, held for 17 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 17 days |
| Price at the screen | $79.89 |
| Valuation | 15.05 trailing · 11.00 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.90 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Aerospace & Defense | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience OverlayThe quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Cited by AFSC divest list for manufacturing military aircraft, armored vehicles, and weapons systems supplied to conflict zones. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Our framework reads AVOID: it trades at roughly a 44% discount to our $115.00 fair value, narrow competitive moat, 3.00% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 43.9% margin of safety to the base estimate.
Third-party analyst targets: 15 covering, consensus Buy. The average target sits +25% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsTextron trips on defence work before numbers matter
Textron keeps Bell helicopters and Cessna jets moving through government and corporate hands every year. We pass because the business activity screen rules out any stake on ethical grounds, full stop.
Revenue climbs 12 percent yet the 6 percent profit margin and 12 percent ROE sit behind a narrow moat. The 12.6 times forward multiple and 26 percent gap to fair value cannot override that hard block.
Defence cycles add their own swings while 16 analysts still push a 100 dollar target. Analysis, not advice.
| Forward P/E | 11.0xexpensive even after accounting for its growth |
| Trailing P/E | 15.0xreasonably valued |
| EPS, trailing | 5.31 |
| EPS, forward | 7.26 |
| Revenue growth | +3.0%slow but positive growth |
| Profit margin | 6.1%thin but positive margins |
| Return on equity | 12.1%a solid return on shareholder capital |
| FCF yield | 3.30% |
| Dividend yield | 9.00% |
| Debt to equity | 0.52moderate, manageable leverage |
| Current ratio | 1.86healthy short-term liquidity |
| Beta | 0.90steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 78.12 - 101.57 |
| Moat | NARROW |
| Market cap | $13.7B |
| Employees | 34,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTXT trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (16 analysts) rates it buy, with a mean price target of $103.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | CLARK RONALD KERRY | Director | 2,517 | $234,308 | |
| 2026-05-01 | KENNEDY THOMAS A | Director | 10,300 | $988,594 | |
| 2026-04-29 | KENNEDY THOMAS A | Director | 2,061 | · | |
| 2026-04-29 | CLARK RONALD KERRY | Director | 2,061 | · | |
| 2026-04-29 | NOWELL LIONEL L III | Director | 2,061 | · | |
| 2026-04-29 | JAMES DEBORAH LEE | Director | 2,061 | · | |
| 2026-04-29 | AMBROSE RICHARD F. | Director | 2,061 | · | |
| 2026-04-29 | ZUBER MARIA T. | Director | 2,061 | · | |
| 2026-04-29 | MIONIS ROBERT ANDREW | Director | 2,061 | · | |
| 2026-04-29 | GARRETT MICHAEL X | Director | 2,061 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 27 Mar2026 | Alan Armstrong | Republican | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $91.66 | -0.3% | · | $997 | -0.3% |
| 2 months | $91.39 | 0.0% | · | $1,000 | 0.0% |
| 3 months | $91.52 | -0.2% | $0.02 | $999 | -0.1% |
| 6 months | $86.81 | +5.2% | $0.04 | $1,053 | +5.3% |
| 1 year | $77.78 | +17.5% | $0.08 | $1,176 | +17.6% |
| 2 years | $86.17 | +6.0% | $0.16 | $1,062 | +6.2% |
| 3 years | $65.12 | +40.3% | $0.22 | $1,406 | +40.6% |
| 5 years | $68.04 | +34.3% | $0.38 | $1,348 | +34.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TXT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.